Residual Disease Driven Strategy for CARCIK (CD19) in Adults/Pediatric BCP-ALL

Clinical trial NCT05252403 · UNKNOWN

Trial details

NCT number: NCT05252403
Sponsor: Fondazione Matilde Tettamanti Menotti De Marchi Onlus
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia

Start date: 2021-12-01
Primary completion: 2024-12-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.